US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

SITE Centers Corp.

11.50

+0.09000.79%

Post-market: 11.500.00000.00%17:36 EDT

Volume:1.33M

Turnover:15.23M

Market Cap:603.12M

PE:1.11

High:11.56

Open:11.52

Low:11.36

Close:11.41

Loading ...

Overview Company News Filings

Wells Fargo Sticks to Its Hold Rating for SITE Centers (SITC)

Site Centers Corp reports results for the quarter ended March 31 - Earnings Summary

SITE Centers Q1 FFO $0.16 Misses $0.18 Estimate, Sales $40.34M Beat $28.89M Estimate

BRIEF-SITE Centers Q1 Net Income USD 3.1 Million Vs. IBES Estimate USD -5.41 Million

Site Centers Corp expected to post a loss of 11 cents a share - Earnings Preview

Press Release: SITE Centers' First Quarter 2025 Earnings to be Released Wednesday, May 7, 2025

Brixmor Property (BRX) Beats Q1 FFO and Revenue Estimates

Site Centers Corp expected to post a loss of 22 cents a share - Earnings Preview

Associated Banc-Corp (ASB) Surpasses Q1 Earnings Estimates

Should You Retain SITE Centers Stock in Your Portfolio Now?

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update

ACCESS Newswire

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment

ACCESS Newswire

Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors

Press Release: CStone Pharmaceuticals Announces 2024 Annual Results and Recent Business Progress

Press Release: TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update

Press Release: Innate Pharma Reports Full Year 2024 Financial Results and Business Update

SITE Centers Is Maintained at Equal-Weight by Wells Fargo

Adaptimmune Provides Q4 and Full Year 2024 Business Update

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update

Press Release: Candel Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SITC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SITC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SITC\",,,,,undefined,":{"symbol":"SITC","market":"US","secType":"STK","nameCN":"SITE Centers Corp.","latestPrice":11.5,"timestamp":1750104000000,"preClose":11.41,"halted":0,"volume":1327472,"hourTrading":{"tag":"盘后","latestPrice":11.5,"preClose":11.5,"latestTime":"17:36 EDT","volume":262144,"amount":3014656,"timestamp":1750109799026},"delay":0,"floatShares":52249855,"shares":52444898,"eps":10.323074,"marketStatus":"Post-Mkt","change":0.09,"latestTime":"06-16 18:37:41 EDT","open":11.52,"high":11.56,"low":11.36,"amount":15228591.522528,"amplitude":0.017528,"askPrice":13.57,"askSize":100,"bidPrice":10.52,"bidSize":100,"shortable":3,"etf":0,"ttmEps":10.323074,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1750118400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":11.41,"aum":0,"dividendRate":0.045217,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":11.5,"preClose":11.5,"latestTime":"17:36 EDT","volume":262144,"amount":3014656,"timestamp":1750109799026},"volumeRatio":1.382951,"impliedVol":0.3341,"impliedVolPercentile":0.759},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SITC\",,,,,undefined,":{"symbol":"SITC","floatShares":52249855,"roa":"0.65%","roe":"42.51%","lyrEps":9.805489,"volumeRatio":1.382951,"shares":52444898,"dividePrice":0.52,"high":11.56,"amplitude":0.017528,"preClose":11.41,"low":11.36,"week52Low":10.455,"pbRate":"1.16","psRate":"2.65","week52High":64.44,"institutionHeld":0.9524,"latestPrice":11.5,"eps":10.323074,"divideRate":0.045217,"volume":1327472,"delay":0,"ttmEps":10.323074,"open":11.52,"prevYearClose":15.29,"prevWeekClose":11.41,"prevMonthClose":11.92,"prevQuarterClose":12.84,"fiveDayClose":12.05,"twentyDayClose":12.5,"sixtyDayClose":12.8},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SITC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2540276700","title":"Wells Fargo Sticks to Its Hold Rating for SITE Centers (SITC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2540276700","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540276700?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:36","pubTimestamp":1748864180,"startTime":"0","endTime":"0","summary":"In a report released today, Dori Kesten from Wells Fargo maintained a Hold rating on SITE Centers (SITC – Research Report), with a price target of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wells-fargo-sticks-to-its-hold-rating-for-site-centers-sitc-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wells-fargo-sticks-to-its-hold-rating-for-site-centers-sitc-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SITC","SITE"],"gpt_icon":0},{"id":"2533946317","title":"Site Centers Corp reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2533946317","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533946317?lang=en_us&edition=fundamental","pubTime":"2025-05-08 12:05","pubTimestamp":1746677158,"startTime":"0","endTime":"0","summary":"Site Centers Corp reports results for the quarter ended March 31 - Earnings SummarySite Centers Corp SITC.N reported quarterly adjusted earnings of 6 cents per share for the quarter ended March 31, hi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nL8N3RG09F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SITC"],"gpt_icon":0},{"id":"2533692679","title":"SITE Centers Q1 FFO $0.16 Misses $0.18 Estimate, Sales $40.34M Beat $28.89M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533692679","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533692679?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:16","pubTimestamp":1746648965,"startTime":"0","endTime":"0","summary":"SITE Centers (NYSE:SITC) reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.18 by 11.11 percent. This is a 85.71 percent decrease over earnings of $1.12 per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45266602/site-centers-q1-ffo-0-16-misses-0-18-estimate-sales-40-34m-beat-28-89m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SITE","SITC"],"gpt_icon":0},{"id":"2533427966","title":"BRIEF-SITE Centers Q1 Net Income USD 3.1 Million Vs. IBES Estimate USD -5.41 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2533427966","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533427966?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:05","pubTimestamp":1746648347,"startTime":"0","endTime":"0","summary":"BRIEF-SITE Centers Q1 Net Income USD 3.1 Million Vs. IBES Estimate USD -5.41 Million\n\n\nMay 07 (Reuters) - SITE Centers Q1 EPS USD 0.06.\n\nQ1 FFO USD 8.3 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nPLXAE27D0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","SITC","BK4080"],"gpt_icon":0},{"id":"2533663225","title":"Site Centers Corp  expected to post a loss of 11 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2533663225","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533663225?lang=en_us&edition=fundamental","pubTime":"2025-05-06 05:03","pubTimestamp":1746478987,"startTime":"0","endTime":"0","summary":"Site Centers Corp  expected to post a loss of11cents a share - Earnings Preview Site Centers Corp SITC.N, SITC.K is expected to show a fall in quarterly revenue when it reports  results on May 7 for t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nL8N3RD2KB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SITC"],"gpt_icon":0},{"id":"2532701826","title":"Press Release: SITE Centers' First Quarter 2025 Earnings to be Released Wednesday, May 7, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2532701826","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532701826?lang=en_us&edition=fundamental","pubTime":"2025-05-01 06:47","pubTimestamp":1746053220,"startTime":"0","endTime":"0","summary":"SITE Centers Corp. , announced today that it intends to release its first quarter earnings after market close on Wednesday, May 7, 2025.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SITE","SITC"],"gpt_icon":0},{"id":"2531912299","title":"Brixmor Property (BRX) Beats Q1 FFO and Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2531912299","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531912299?lang=en_us&edition=fundamental","pubTime":"2025-04-29 05:20","pubTimestamp":1745875203,"startTime":"0","endTime":"0","summary":"Brixmor Property  came out with quarterly funds from operations  of $0.56 per share, beating the Zacks Consensus Estimate of $0.55 per share. This compares to FFO of $0.54 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an FFO surprise of 1.82%. A quarter ago, it was expected that this owner and operator of shopping centers would post FFO of $0.54 per share when it actually produced FFO of $0.53, delivering a surprise of -1.85%.Over the last four quarters, the company has surpassed consensus FFO estimates two times.Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, REIT and Equity Trust - Retail is currently in the top 36% of the 250 plus Zacks industries. Our research","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/brixmor-property-brx-beats-q1-212003118.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SITC","BRX"],"gpt_icon":0},{"id":"2530180579","title":"Site Centers Corp  expected to post a loss of 22 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2530180579","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530180579?lang=en_us&edition=fundamental","pubTime":"2025-04-25 20:32","pubTimestamp":1745584367,"startTime":"0","endTime":"0","summary":"Site Centers Corp  expected to post a loss of22cents a share - Earnings Preview Site Centers Corp SITC.N, SITC.K is expected to show a fall in quarterly revenue when it reports  results on April 28 (e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nL8N3R31A6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SITC"],"gpt_icon":0},{"id":"2530990116","title":"Associated Banc-Corp (ASB) Surpasses Q1 Earnings Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2530990116","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530990116?lang=en_us&edition=fundamental","pubTime":"2025-04-25 05:40","pubTimestamp":1745530805,"startTime":"0","endTime":"0","summary":"Associated Banc-Corp  came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.52 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 3.51%. A quarter ago, it was expected that this bank holding company would post earnings of $0.55 per share when it actually produced earnings of $0.57, delivering a surprise of 3.64%.Associated Banc-Corp , which belongs to the Zacks Banks - Midwest industry, posted revenues of $348.97 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 0.50%. This compares to year-ago revenues of $326.61 million. The company has topped consensus revenue estimates just once over the last four quarters.Associated Banc-Corp shares have lost about 10.4% since the beginning of the year versus the S&P 500's decline of -8.6%.While Associated Banc-Corp has underperformed the market so far","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/associated-banc-corp-asb-surpasses-214005439.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ASB","SITC"],"gpt_icon":0},{"id":"2526618388","title":"Should You Retain SITE Centers Stock in Your Portfolio Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526618388","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526618388?lang=en_us&edition=fundamental","pubTime":"2025-04-11 23:00","pubTimestamp":1744383600,"startTime":"0","endTime":"0","summary":"SITE Centers Corp’s SITC well-located portfolio of retail real estate assets, concentrated mostly in the suburban and high household income regions, positions it well for growth. Its solid tenant roster and focus on the capital-recycling program augur well. However, rising e-commerce adoption and elevated interest rates add to its woes.The company has a solid tenant roster comprising reputed names like TJX Companies, DICK's Sporting Goods, Burlington, Kroger and PetSmart. These tenants hold a relatively strong financial position and have performed well over time. This assures stable rental revenues for the company over the long term.Despite the Federal Reserve announcing rate cuts late in 2024, the interest rate is still high and is a concern for SITE Centers. Elevated rates imply high borrowing costs for the company, affecting its ability to purchase or develop real","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/retain-centers-stock-portfolio-now-150000927.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SITC","BK4585","REG","BK4588","LU1815336091.USD","REIT","LU0757428866.USD","BK4548","LU2065731478.USD","SITE","BK4104","BK4231","BK4080","SKT"],"gpt_icon":0},{"id":"2526923550","title":"CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2526923550","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526923550?lang=en_us&edition=fundamental","pubTime":"2025-04-10 19:30","pubTimestamp":1744284600,"startTime":"0","endTime":"0","summary":"Strategic Milestone Achievement and Increased Financial Discipline Underscore Year of Corporate Transformation. Completed enrollment of Part B of Phase 1 glioblastoma study with investigational precision immunotherapy CVGBM; Part B first data readout anticipated in H2 2025. Filed IND and CTA submissions for Phase 1 study with proprietary off-the-shelf program in squamous non-small cell lung cancer . Received FDA clearance to proceed with sqNSCLC Phase 1 study; expected tostart in H2 2025. Invoiced 10 million milestone payment following initiation of Phase 1 of the combined Phase 1/2 study of a seasonal influenza/COVID-19 combination vaccine; program fully licensed to GSK. Received positive validity decision for patent EP 3 708 668 B1 in amended form from European Patent Office  in inter partes proceedings against BioNTech SE. Cash and cash equivalents position of 481.7 million as of December 31, 2024; reaffirming expected cash runway into 2028. TBINGEN, GERMANY AND BOSTON, MA / ACCESS ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/curevac-announces-financial-results-fourth-113000748.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CVAC","SITC","BK4585","BK4139","BK4535","BK4548","BK4231","BNTX","BK4568","BK4080","BK4588","CTA","BK4551"],"gpt_icon":0},{"id":"2526613364","title":"Xenetic Biosciences, Inc. Releases Virtual Investor \"What This Means\" Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2526613364","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526613364?lang=en_us&edition=fundamental","pubTime":"2025-04-09 21:15","pubTimestamp":1744204500,"startTime":"0","endTime":"0","summary":"- Dr. Reid Bissonnette, Executive Consultant for Translational Research and Development at Xenetic, discusses positive preclinical data recently presented at the Society for Immunotherapy of Cancer  Spring Scientific 2025 Cell Therapy Meeting. FRAMINGHAM, MA / ACCESS Newswire / April 9, 2025 / Xenetic Biosciences, Inc.  , a biopharmaceutical company focused on advancing innovative immune-oncology technologies addressing difficult to treat cancers, today announced thatDr. Reid Bissonnette, Executive Consultant for Translational Research and Development at Xenetic participated in aVirtual Investor \"What This Means\" segment.As part of the segment, Dr. Bissonnette discussed key highlights from the Company's recent poster presentation titled, \"DNase I Intervention Enhances CAR-T Cell Therapy in Solid Tumors by Targeting Neutrophil Extracellular Traps in Metastatic Melanoma,\" which was presented at theat the Society for Immunotherapy of Cancer  Spring Scientific 2025 Cell Therapy Meeting.The","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/xenetic-biosciences-inc-releases-virtual-131500464.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["XBIOW","BK4080","XBIO","BK4231","SITC","BK4139"],"gpt_icon":0},{"id":"2522558078","title":"Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2522558078","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522558078?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:05","pubTimestamp":1743105900,"startTime":"0","endTime":"0","summary":"– Initial clinical activity in a PD-1 resistant population, with an ORR almost three times higher than historical PD-1 rechallenge response rates, with data still maturing –。– One durable complete response in a Merkel Cell Carcinoma  patient and two partial responses , including one in a second MCC patient and one in a microsatellite instability-high  Colorectal Cancer  patient, all of whom were previously treated with and progressed on immunotherapy –。– All PD-1 resistant “hot” tumor patients with tumor shrinkage remain on study, suggesting potential for deepening responses over time –。The Phase 1 dose expansion trial is a multi-center, open-label, dose expansion study evaluating solnerstotug as monotherapy and in combination withLibtayo , Regeneron’s PD-1 inhibitor, in both a basket of “hot” tumorsthat typically respond to immunotherapy but have progressed on prior PD-1 therapy and a single “cold” tumor histology  that is typically unresponsive to immunotherapy.At the time of this da","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sensei-biotherapeutics-reports-favorable-preliminary-200500147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU0053666078.USD","L","SNSE","SITC","BK4113","PD","LU1169589451.USD","IE00B66KJ199.SGD","BK4585","BK4023","IE00B19Z4B17.USD","IE0031619046.USD","BK4588","LU2065731478.USD","IE00B7SZL793.SGD","BK4006","CRS","LU0266512127.USD","SD","PR","BK4231","MSS","BK4080","RCC","BK4213","BK4107","CR","CRC","LU0456854461.SGD","LU1169590202.USD","BK4161"],"gpt_icon":0},{"id":"2522374205","title":"Press Release: CStone Pharmaceuticals Announces 2024 Annual Results and Recent Business Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2522374205","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522374205?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:55","pubTimestamp":1743076500,"startTime":"0","endTime":"0","summary":"-      Total Revenue: RMB 407.2 million, including RMB 232.1 million in licensing and royalty income.-          EU & UK: Approved for first-line treatment of stage IV non-small cell lung cancer ; stage III NSCLC new indication application submitted to EMA.-     Global Partnerships: Three strategic partnerships across 40+ countries, to accelerate global commercialization.-      Localized Production: Approved for localized manufacturing in China, enhancing cost efficiency.-      Commercial Collaboration: Partnered with Hengrui to expand market access in China.-      Leading Position: Top 2 globally in clinical development for ROR1-targeted ADCs.-      Preclinical Differentiation: Superior tumor suppression vs. benchmarked competitors; potential first-in-class/best-in-class IO backbone therapy.-      More than 9 Differentiated Candidates: Focus on first-in-class/best-in-class assets, including multispecific antibodies and ADCs, with global rights and broad therapeutic potential.SUZHOU, Ch","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HL","02616","BK4541","BK4124","BK1161","PRGS","PFS","CDE","LU0823414478.USD","LU2463526074.USD","LU0957808578.USD","SOC","SITC","OS","BK4080","BK4182","BK4570","LU2065732104.USD","ADC","BK4232","ORR","CPS","BK4213","BK4109","LU2357125470.USD","LU0823414551.USD","BK4022","BK4210","LU1815336760.USD","BK4588","R","LU2506951792.HKD","BE","ASH","BK4585","LU0444971666.USD","LU2294711713.HKD","BK4211","BK4195","BK4231","CEE","LU1642822529.SGD","BK1574","LU2249611893.SGD","LU0476273544.USD","LU0345780521.USD","LU0444973449.USD","BK4017","BK4097"],"gpt_icon":0},{"id":"2522379271","title":"Press Release: TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2522379271","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522379271?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:30","pubTimestamp":1743075000,"startTime":"0","endTime":"0","summary":"-- Revenues of $8.3 Million in Q4 and $29.4 Million for Full-Year 2024,Representing Growth of 44% And 59%, Respectively, Versus the Prior Year. -- Gross Margin of 85% and 86% for Q4 and Full-Year 2024. 20% Reduction in Operating Expenses, Positive EBITDA, and Positive Cash. \"We were also pleased to strengthen our Board of Directors with the additions of William Valle and Dr. Gary Gordon. Additionally, we want to sincerely thank Sean Murphy for his leadership in guiding the Company through the process of going public, a milestone that would not have been possible without his dedication and expertise. We are thrilled to welcome him back to the Board of Directors and look forward to his continued contributions to our success,\" concluded Ms. Szela.These new products are eligible for the same HCPCS reimbursement codes as existing TriNav products, which should enable seamless integration into current billing structures. The Company believes these expanded features","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","SITC","BK4208","BK4604","R","LU1894683264.USD","LU1894683348.USD","BK4099","BK4231","TM","BK4022","BK4555","LU2637428348.USD","BK4585","03160","LU2346227817.USD","BK4139","BK4080","CMS","BK4588","TLSI","LU2500361329.USD"],"gpt_icon":0},{"id":"2522193123","title":"Press Release: Innate Pharma Reports Full Year 2024 Financial Results and Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2522193123","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522193123?lang=en_us&edition=fundamental","pubTime":"2025-03-27 14:00","pubTimestamp":1743055200,"startTime":"0","endTime":"0","summary":"-- FDA Breakthrough Therapy Designation granted to lacutamab for relapsed or. -- New data, including lacutamab improved health-related quality of. life data from TELLOMAK Phase 2 study in patients with cutaneous T. -- IPH6501, Innate's proprietary ANKET drug candidate, is being evaluated. -- Innate Pharma and the Institute for Follicular Lymphoma Innovation. Innate Pharma SA   today reported its consolidated financial results for the year ending December 31, 2024. The consolidated financial statements are attached to this press release.\"Our strategy is clear: drive innovation through our ANKET NK-cell engager platform and accelerate our ADC programs. We are making strong clinical progress, with our lead proprietary ANKET , IPH6501 advancing in B-cell non-Hodgkin's lymphoma and commencing the Phase 1 study for the Nectin-4 ADC IPH4502 in solid tumors. The FDA's Breakthrough Therapy Designation for lacutamab highlights its potential to transform treatment for Sézary syndrome. With these ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4094","FL","IPHYF","R","BK4022","BK4139","BK4588","SITC","IPHA","BK4080","BK4231","BK4585"],"gpt_icon":0},{"id":"2522805834","title":"SITE Centers Is Maintained at Equal-Weight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2522805834","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522805834?lang=en_us&edition=fundamental","pubTime":"2025-03-26 21:00","pubTimestamp":1742994000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SITC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 26, 2025 09:00 ET (13:00 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0971096721.USD","LU1363072403.SGD","LU1668664300.SGD","LU1814569148.SGD","LU1267930490.SGD","LU0128525689.USD","LU0029864427.USD","LU0154236417.USD","LU0128525929.USD","BK4104","LU0070302665.USD","IE0002270589.USD","LU0048573561.USD","LU0251131958.USD","LU1069347547.HKD","LU0106831901.USD","LU0640476718.USD","SITE","LU0211327993.USD","LU1267930573.SGD","LU0208291251.USD","LU2361044949.HKD","BK4231","LU1267930227.SGD","LU0310800379.SGD","LU2361045086.USD","BK4588","LU0149725797.USD","LU2065731478.USD","BK4585","LU0314106906.USD","SITC","LU0175139822.USD","LU0477156953.USD","LU1506573853.SGD","LU0267386448.USD","LU2236285917.USD","LU0162691827.USD","LU0130102774.USD","BK4504","LU0052756011.USD","IE00B7SZLL34.SGD","LU0708994859.HKD","LU2461242641.AUD","LU0072461881.USD","LU1074936037.SGD","LU1035773651.USD","BK4501","LU0683600562.USD"],"gpt_icon":0},{"id":"2520743010","title":"Adaptimmune Provides Q4 and Full Year 2024 Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2520743010","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520743010?lang=en_us&edition=fundamental","pubTime":"2025-03-20 19:00","pubTimestamp":1742468400,"startTime":"0","endTime":"0","summary":"TECELRA launch momentum accelerating– 10 patients apheresed in Q1 2025 and 3 in 2024; 20 ATCs available; all manufacturing and supply goals achieved. Lete-cel on track to initiate rolling BLA submission late 2025; approval anticipated 2026. Corporate restructure completed in February 2025 and implementing additional cost reduction for PRAME and CD70 programs. At the end of 2024, Adaptimmune had Total Liquidity1 of $152 million. Adrian Rawcliffe, Adaptimmune's Chief Executive Officer: \"2025 is the year of commercial execution for Tecelra, as we begin to generate value from our promising sarcoma franchise. The launch is going very well and each step in delivering this important medicine: activating our treatment network; identifying biomarker eligible patients; exceptional manufacturing quality and turn-around times, strengthens our sarcoma platform capabilities for both Tecelra and for lete-cel. These results give us confidence in our strategy to build value from our sarcoma franchise a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/adaptimmune-provides-q4-full-2024-110000539.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adaptimmune-provides-q4-full-2024-110000539.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SITC","BK4231","BK4139","ADAP","BK4080"],"gpt_icon":0},{"id":"2519389886","title":"Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2519389886","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519389886?lang=en_us&edition=fundamental","pubTime":"2025-03-14 06:07","pubTimestamp":1741903620,"startTime":"0","endTime":"0","summary":"○ UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) granted by FDA and ODD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/13/3042670/0/en/Cellectis-Reports-Financial-Results-for-the-Fourth-Quarter-and-Full-Year-2024-and-Provides-a-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC","ODD","BK4183","BK4139","SITC","RCC","CLLS","BK4201","BK4231","BK4080","BK4230","BK4022","CAR"],"gpt_icon":0},{"id":"2519586929","title":"Press Release: Candel Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2519586929","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519586929?lang=en_us&edition=fundamental","pubTime":"2025-03-14 04:15","pubTimestamp":1741896900,"startTime":"0","endTime":"0","summary":"Candel Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights. -- Recently announced positive data from pivotal randomized,placebo-controlled phase 3 clinical trial of CAN-2409 in. prostate cancer underway, with submission expected in Q4 2026. Dr. Tak continued, \"We enter 2025 well-resourced with a clear direction and mandate. Our primary focus for the year is working toward readiness to submit CAN-2409's BLA for prostate cancer, a key opportunity to address a very significant unmet need and opportunity for value creation. In addition, we continue to explore the efficacy of CAN-2409 in other indications, as evidenced by our recently disclosed positive final overall survival data for CAN-2409 in a randomized controlled phase 2a trial in borderline resectable pancreatic cancer. This result has triggered enabling work, which will include scientific advisory boards and engagement with the FDA, to get ready for a larger, late-stage, randomiz","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","03160","BK4080","BK4600","LU1668664300.SGD","BK4231","SITC","BK4139","BK4555","BK4166","BK4588","BK4526","BK4170","BK4595","BK4585","LU0106831901.USD","BK4539","LU2360107671.USD","CADL","TM","LU1861220207.SGD","BK4099","DFS","LU1791807156.HKD","LU1861217088.USD","LENZ"],"gpt_icon":1}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":65,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SITC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"SITC","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":0.16},{"market":"US","date":"2025-02-27","symbol":"SITC","fiscalQuarterEnding":"2024/12","expectedEps":0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":0.16},{"market":"US","date":"2024-10-30","symbol":"SITC","fiscalQuarterEnding":"2024/09","expectedEps":0.87,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730260800000,"reportTimeType":"pre","actualEps":0.81},{"market":"US","date":"2024-08-19","symbol":"SITC","defaultRemindTime":1724074200000,"type":"split","dateTimestamp":1724040000000,"forFactor":4,"toFactor":1,"ratio":4},{"date":"2024-07-30","symbol":"SITC","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722326400000,"name":null,"time":"Pre-Market","dateTimestamp":1722312000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SITC\",market:\"US\",,,undefined,":[{"executeDate":"2015-09-18","recordDate":"2015-09-22","paymentDate":"2015-10-09","value":0.1725,"currency":"USD"},{"executeDate":"2015-12-11","recordDate":"2015-12-15","paymentDate":"2016-01-05","value":0.1725,"currency":"USD"},{"executeDate":"2016-03-08","recordDate":"2016-03-10","paymentDate":"2016-04-05","value":0.19,"currency":"USD"},{"executeDate":"2016-06-07","recordDate":"2016-06-09","paymentDate":"2016-07-06","value":0.19,"currency":"USD"},{"executeDate":"2016-09-21","recordDate":"2016-09-23","paymentDate":"2016-10-11","value":0.19,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SITC\",market:\"US\",delay:true,,,undefined,":{"strongBuy":0,"buy":0.2,"hold":0.8,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.8,"analysts":5,"updateTime":1728273600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SITC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:true,algorithm:1,,,undefined,":{"brief":{"id":"SITC","date":"2025-06-13","current":1.115647,"percent":0.056876,"low":0.676862,"twenty":10.945567,"median":19.867235,"eighty":48.464304,"high":191.31255,"avg":33.515659,"sd":41.843298,"marketCap":623045388},"quantilePoints":[{"date":"2020-06-19","current":14.743984,"twenty":-26.648569,"median":9.86282,"eighty":24.16559,"marketCap":1463222456},{"date":"2020-06-26","current":14.49045,"twenty":-26.407324,"median":9.953304,"eighty":24.16559,"marketCap":1438061223},{"date":"2020-07-02","current":15.504586,"twenty":-26.133311,"median":10.028708,"eighty":24.16559,"marketCap":1538706154},{"date":"2020-07-10","current":14.665973,"twenty":-25.913845,"median":10.102322,"eighty":24.16559,"marketCap":1455480538},{"date":"2020-07-17","current":14.061392,"twenty":-25.711202,"median":10.179516,"eighty":24.16559,"marketCap":1395480676},{"date":"2020-07-24","current":13.495816,"twenty":-24.931447,"median":10.239839,"eighty":24.16559,"marketCap":1339351772},{"date":"2020-07-31","current":18.340911,"twenty":-22.406996,"median":10.307702,"eighty":24.16559,"marketCap":1418706128},{"date":"2020-08-07","current":19.516931,"twenty":-21.330192,"median":10.413749,"eighty":24.055579,"marketCap":1509673643},{"date":"2020-08-14","current":20.167495,"twenty":-21.330192,"median":10.413749,"eighty":23.592655,"marketCap":1559996098},{"date":"2020-08-21","current":18.491041,"twenty":-21.330192,"median":10.413749,"eighty":23.022214,"marketCap":1430319003},{"date":"2020-08-28","current":19.491909,"twenty":-21.330192,"median":10.413749,"eighty":22.482127,"marketCap":1507738164},{"date":"2020-09-04","current":20.768016,"twenty":-21.330192,"median":10.413749,"eighty":21.985969,"marketCap":1606447594},{"date":"2020-09-11","current":18.866367,"twenty":-21.330192,"median":10.413749,"eighty":21.745755,"marketCap":1459351188},{"date":"2020-09-18","current":19.341779,"twenty":-21.330192,"median":10.413749,"eighty":21.65885,"marketCap":1496125290},{"date":"2020-09-25","current":17.164891,"twenty":-21.330192,"median":10.413749,"eighty":21.442484,"marketCap":1327738614},{"date":"2020-10-02","current":19.06654,"twenty":-21.330192,"median":10.413749,"eighty":21.277267,"marketCap":1474835020},{"date":"2020-10-09","current":19.266714,"twenty":-21.330192,"median":10.413749,"eighty":21.073882,"marketCap":1490318853},{"date":"2020-10-16","current":18.265846,"twenty":-21.330192,"median":10.413749,"eighty":20.884694,"marketCap":1412899691},{"date":"2020-10-23","current":19.21667,"twenty":-21.330192,"median":10.413749,"eighty":20.760363,"marketCap":1486447895},{"date":"2020-10-30","current":21.583486,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":1316786918},{"date":"2020-11-06","current":21.805343,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":1330322173},{"date":"2020-11-13","current":29.158308,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":1778919185},{"date":"2020-11-20","current":32.866484,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2005151298},{"date":"2020-11-27","current":33.880686,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2067026748},{"date":"2020-12-04","current":33.595441,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2049624278},{"date":"2020-12-11","current":32.612933,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":1989682436},{"date":"2020-12-18","current":32.264301,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":1968412750},{"date":"2020-12-24","current":32.42277,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":1978080789},{"date":"2020-12-31","current":32.074138,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":1956811103},{"date":"2021-01-08","current":32.612933,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":1989682436},{"date":"2021-01-15","current":36.257722,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2212047334},{"date":"2021-01-22","current":36.035865,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2198512079},{"date":"2021-01-29","current":35.148438,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2144371061},{"date":"2021-02-05","current":36.733129,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2241051451},{"date":"2021-02-12","current":39.046777,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2382204821},{"date":"2021-02-19","current":69.717994,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2490396480},{"date":"2021-02-26","current":72.267886,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2581481162},{"date":"2021-03-05","current":71.809955,"twenty":-21.346772,"median":10.405985,"eighty":20.72975,"marketCap":2565123415},{"date":"2021-03-12","current":77.175378,"twenty":-21.346772,"median":10.405985,"eighty":20.72975,"marketCap":2756781692},{"date":"2021-03-19","current":72.731291,"twenty":-21.346772,"median":10.405985,"eighty":20.72975,"marketCap":2598034432},{"date":"2021-03-26","current":72.948075,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2605778201},{"date":"2021-04-01","current":81.578891,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":2914079580},{"date":"2021-04-09","current":81.815352,"twenty":-21.346772,"median":10.405985,"eighty":20.72975,"marketCap":2922526188},{"date":"2021-04-16","current":83.175,"twenty":-21.346772,"median":10.405985,"eighty":20.72975,"marketCap":2971094181},{"date":"2021-04-23","current":181.722513,"twenty":-21.346772,"median":10.405985,"eighty":20.72975,"marketCap":3161244840},{"date":"2021-04-30","current":179.052037,"twenty":-21.330192,"median":10.413749,"eighty":20.72975,"marketCap":3114789242},{"date":"2021-05-07","current":179.416211,"twenty":-21.031751,"median":10.45851,"eighty":20.808051,"marketCap":3121124406},{"date":"2021-05-14","current":179.29482,"twenty":-20.26078,"median":10.628891,"eighty":20.953183,"marketCap":3119012685},{"date":"2021-05-21","current":174.439171,"twenty":-19.86286,"median":10.760125,"eighty":21.17332,"marketCap":3034543824},{"date":"2021-05-28","current":181.722644,"twenty":-19.59758,"median":10.843553,"eighty":21.350211,"marketCap":3161247115},{"date":"2021-06-04","current":182.936556,"twenty":-19.353025,"median":10.873231,"eighty":21.458393,"marketCap":3182364330},{"date":"2021-06-11","current":190.584202,"twenty":-19.149919,"median":10.903393,"eighty":21.641205,"marketCap":3315402786},{"date":"2021-06-18","current":176.409606,"twenty":-18.959249,"median":10.936392,"eighty":21.742594,"marketCap":3068821509},{"date":"2021-06-25","current":181.236134,"twenty":-18.814174,"median":10.978796,"eighty":21.900316,"marketCap":3152783794},{"date":"2021-07-02","current":180.029502,"twenty":-18.727129,"median":11.057988,"eighty":22.173572,"marketCap":3131793223},{"date":"2021-07-09","current":182.684093,"twenty":-18.586199,"median":11.106983,"eighty":22.491948,"marketCap":3177972479},{"date":"2021-07-16","current":180.874145,"twenty":-18.233873,"median":11.137144,"eighty":22.927256,"marketCap":3146486622},{"date":"2021-07-23","current":182.925419,"twenty":-17.939578,"median":11.182387,"eighty":23.358886,"marketCap":3182170593},{"date":"2021-07-30","current":76.747214,"twenty":-16.640313,"median":11.272517,"eighty":23.834401,"marketCap":3367514261},{"date":"2021-08-06","current":77.618242,"twenty":-13.565429,"median":11.299781,"eighty":24.16559,"marketCap":3405733212},{"date":"2021-08-13","current":75.972967,"twenty":-13.112133,"median":11.361721,"eighty":24.324535,"marketCap":3333541859},{"date":"2021-08-20","current":75.15033,"twenty":-12.911344,"median":11.454504,"eighty":24.606186,"marketCap":3297446183},{"date":"2021-08-27","current":78.392489,"twenty":-12.075456,"median":11.512149,"eighty":24.862689,"marketCap":3439705613},{"date":"2021-09-03","current":78.198927,"twenty":-11.874284,"median":11.597108,"eighty":25.159211,"marketCap":3431212513},{"date":"2021-09-10","current":73.940569,"twenty":-11.75983,"median":11.640455,"eighty":25.890766,"marketCap":3244364306},{"date":"2021-09-17","current":76.166529,"twenty":-11.543848,"median":11.70682,"eighty":26.965347,"marketCap":3342034960},{"date":"2021-09-24","current":75.440673,"twenty":-11.486784,"median":11.716711,"eighty":27.504909,"marketCap":3310185834},{"date":"2021-10-01","current":78.102146,"twenty":-11.402384,"median":11.75737,"eighty":30.033057,"marketCap":3426965962},{"date":"2021-10-08","current":79.74742,"twenty":-11.350665,"median":11.786459,"eighty":31.459278,"marketCap":3499157315},{"date":"2021-10-15","current":80.957181,"twenty":-11.268524,"median":11.806148,"eighty":32.112171,"marketCap":3552239192},{"date":"2021-10-22","current":79.457078,"twenty":-11.223146,"median":11.817362,"eighty":32.264301,"marketCap":3486417664},{"date":"2021-10-29","current":52.174647,"twenty":-11.138413,"median":11.840788,"eighty":32.536868,"marketCap":3373351803},{"date":"2021-11-05","current":56.705862,"twenty":-11.085883,"median":11.869677,"eighty":32.866484,"marketCap":3666317535},{"date":"2021-11-12","current":54.735769,"twenty":-11.037694,"median":11.879948,"eighty":33.08834,"marketCap":3538941130},{"date":"2021-11-19","current":54.47309,"twenty":-10.975399,"median":11.890583,"eighty":33.690522,"marketCap":3521957609},{"date":"2021-11-26","current":51.911968,"twenty":-10.953528,"median":11.911488,"eighty":34.888549,"marketCap":3356368282},{"date":"2021-12-03","current":50.532902,"twenty":-10.89362,"median":11.945735,"eighty":35.560457,"marketCap":3267204798},{"date":"2021-12-10","current":50.138884,"twenty":-10.817339,"median":11.974047,"eighty":36.333787,"marketCap":3241729517},{"date":"2021-12-17","current":49.219507,"twenty":-10.600022,"median":12.007676,"eighty":37.012034,"marketCap":3182287194},{"date":"2021-12-23","current":50.007544,"twenty":-10.56133,"median":12.028522,"eighty":38.153012,"marketCap":3233237757},{"date":"2021-12-31","current":51.977638,"twenty":-10.39631,"median":12.06347,"eighty":44.31339,"marketCap":3360614162},{"date":"2022-01-07","current":52.634336,"twenty":-9.93569,"median":12.078465,"eighty":48.589077,"marketCap":3403072964},{"date":"2022-01-14","current":52.568666,"twenty":-9.638521,"median":12.105553,"eighty":49.71203,"marketCap":3398827084},{"date":"2022-01-21","current":47.938946,"twenty":-9.582274,"median":12.145744,"eighty":50.033812,"marketCap":3099492531},{"date":"2022-01-28","current":49.121002,"twenty":-9.497901,"median":12.173878,"eighty":50.020678,"marketCap":3175918374},{"date":"2022-02-04","current":48.10312,"twenty":-9.334514,"median":12.273341,"eighty":50.020678,"marketCap":3110107231},{"date":"2022-02-11","current":25.801244,"twenty":-9.280832,"median":12.332854,"eighty":50.020678,"marketCap":3223478403},{"date":"2022-02-18","current":26.190377,"twenty":-9.20764,"median":13.101808,"eighty":50.020678,"marketCap":3272094798},{"date":"2022-02-25","current":27.08718,"twenty":-9.116217,"median":13.301412,"eighty":50.020678,"marketCap":3384136804},{"date":"2022-03-04","current":27.070261,"twenty":-9.081397,"median":13.410358,"eighty":50.020678,"marketCap":3382023040},{"date":"2022-03-11","current":27.188693,"twenty":-8.932741,"median":13.565493,"eighty":50.020678,"marketCap":3396819390},{"date":"2022-03-18","current":27.662423,"twenty":-8.804174,"median":13.68492,"eighty":50.020678,"marketCap":3456004794},{"date":"2022-03-25","current":27.39172,"twenty":-8.566101,"median":13.926879,"eighty":50.020678,"marketCap":3422184563},{"date":"2022-04-01","current":28.491854,"twenty":-8.494418,"median":14.014538,"eighty":50.020678,"marketCap":3559629780},{"date":"2022-04-08","current":27.224423,"twenty":-8.455252,"median":14.140785,"eighty":50.020678,"marketCap":3401283260},{"date":"2022-04-14","current":27.731395,"twenty":-8.413437,"median":14.285152,"eighty":50.020678,"marketCap":3464621868},{"date":"2022-04-22","current":27.900386,"twenty":-8.335201,"median":14.519704,"eighty":50.020678,"marketCap":3485734737},{"date":"2022-04-29","current":27.689747,"twenty":-8.214908,"median":14.675724,"eighty":50.020678,"marketCap":3402073026},{"date":"2022-05-06","current":26.74934,"twenty":-8.105599,"median":14.753735,"eighty":50.020678,"marketCap":3286530923},{"date":"2022-05-13","current":26.226892,"twenty":-8.073018,"median":14.835984,"eighty":50.020678,"marketCap":3222340866},{"date":"2022-05-20","current":24.119685,"twenty":-8.034568,"median":14.935298,"eighty":50.020678,"marketCap":2963440969},{"date":"2022-05-27","current":27.863896,"twenty":-7.999038,"median":15.080449,"eighty":50.020678,"marketCap":3423469712},{"date":"2022-06-03","current":26.74934,"twenty":-7.950425,"median":15.095031,"eighty":50.020678,"marketCap":3286530923},{"date":"2022-06-10","current":23.823631,"twenty":-7.90537,"median":15.234506,"eighty":50.020678,"marketCap":2927066603},{"date":"2022-06-17","current":22.674245,"twenty":-7.776056,"median":15.309635,"eighty":50.020678,"marketCap":2785848478},{"date":"2022-06-24","current":23.858461,"twenty":-7.729466,"median":15.462379,"eighty":50.033812,"marketCap":2931345940},{"date":"2022-07-01","current":23.753971,"twenty":-7.570482,"median":15.660607,"eighty":50.033812,"marketCap":2918507929},{"date":"2022-07-08","current":23.231523,"twenty":-7.513609,"median":15.75812,"eighty":50.033812,"marketCap":2854317872},{"date":"2022-07-15","current":23.318598,"twenty":-7.390816,"median":17.01476,"eighty":50.033812,"marketCap":2865016215},{"date":"2022-07-22","current":24.224175,"twenty":-7.304216,"median":17.915542,"eighty":50.033812,"marketCap":2976278980},{"date":"2022-07-29","current":19.389716,"twenty":-7.195641,"median":18.065672,"eighty":50.033812,"marketCap":3129209334},{"date":"2022-08-05","current":18.580152,"twenty":-7.014684,"median":18.26585,"eighty":50.033812,"marketCap":2998557884},{"date":"2022-08-12","current":19.933849,"twenty":-7.014684,"median":18.491041,"eighty":50.033812,"marketCap":3217024244},{"date":"2022-08-19","current":19.190643,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":3097081928},{"date":"2022-08-26","current":17.903304,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2889324703},{"date":"2022-09-02","current":17.000839,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2743680463},{"date":"2022-09-09","current":17.823675,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2876473741},{"date":"2022-09-16","current":17.027382,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2747964117},{"date":"2022-09-23","current":14.996837,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2420264577},{"date":"2022-09-30","current":14.213817,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2293896781},{"date":"2022-10-07","current":14.187273,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2289613127},{"date":"2022-10-14","current":14.492519,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2338875149},{"date":"2022-10-21","current":15.341897,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2475952081},{"date":"2022-10-28","current":13.19515,"twenty":-7.014684,"median":18.641171,"eighty":50.033812,"marketCap":2632643607},{"date":"2022-11-04","current":13.216467,"twenty":-7.014684,"median":18.61615,"eighty":50.033812,"marketCap":2636896666},{"date":"2022-11-11","current":13.983875,"twenty":-7.014684,"median":18.491041,"eighty":50.033812,"marketCap":2790006795},{"date":"2022-11-18","current":14.090459,"twenty":-7.014684,"median":18.354536,"eighty":50.033812,"marketCap":2811272091},{"date":"2022-11-25","current":14.229019,"twenty":-7.014684,"median":18.265846,"eighty":50.033812,"marketCap":2838916975},{"date":"2022-12-02","current":14.420871,"twenty":-7.014684,"median":18.022748,"eighty":50.033812,"marketCap":2877194508},{"date":"2022-12-09","current":14.143752,"twenty":-7.014684,"median":17.915542,"eighty":50.033812,"marketCap":2821904739},{"date":"2022-12-16","current":13.962558,"twenty":-7.014684,"median":17.61133,"eighty":50.033812,"marketCap":2785753736},{"date":"2022-12-23","current":14.516797,"twenty":-7.014684,"median":17.199912,"eighty":50.033812,"marketCap":2896333274},{"date":"2022-12-30","current":14.559431,"twenty":-7.014684,"median":17.053926,"eighty":50.033812,"marketCap":2904839392},{"date":"2023-01-06","current":13.930583,"twenty":-7.014684,"median":16.934482,"eighty":49.311445,"marketCap":2779374147},{"date":"2023-01-13","current":14.090459,"twenty":-7.014684,"median":16.483249,"eighty":48.726983,"marketCap":2811272091},{"date":"2023-01-20","current":13.728072,"twenty":-7.014684,"median":15.75812,"eighty":48.536541,"marketCap":2738970086},{"date":"2023-01-27","current":14.314287,"twenty":-7.014684,"median":15.639909,"eighty":48.346098,"marketCap":2855929212},{"date":"2023-02-03","current":14.697991,"twenty":-7.014684,"median":15.341897,"eighty":47.722236,"marketCap":2932484277},{"date":"2023-02-10","current":17.431293,"twenty":-7.014684,"median":15.251052,"eighty":38.894647,"marketCap":2940990395},{"date":"2023-02-17","current":17.343066,"twenty":8.24554,"median":15.341897,"eighty":38.102301,"marketCap":2926104688},{"date":"2023-02-24","current":16.869169,"twenty":9.088908,"median":15.504586,"eighty":38.102301,"marketCap":2846149307},{"date":"2023-03-03","current":16.582193,"twenty":9.410881,"median":15.699613,"eighty":38.102301,"marketCap":2797731086},{"date":"2023-03-10","current":15.184747,"twenty":9.562713,"median":15.855634,"eighty":38.102301,"marketCap":2561955404},{"date":"2023-03-17","current":14.585842,"twenty":9.657722,"median":15.855634,"eighty":38.102301,"marketCap":2460908683},{"date":"2023-03-24","current":14.336298,"twenty":9.754238,"median":15.855634,"eighty":38.102301,"marketCap":2418805882},{"date":"2023-03-31","current":15.321997,"twenty":9.852263,"median":15.82638,"eighty":38.051591,"marketCap":2585111944},{"date":"2023-04-06","current":14.872818,"twenty":9.90203,"median":15.82638,"eighty":38.051591,"marketCap":2509326903},{"date":"2023-04-14","current":14.735568,"twenty":10.022676,"median":15.855634,"eighty":38.102301,"marketCap":2486170363},{"date":"2023-04-21","current":14.880945,"twenty":10.100022,"median":15.855634,"eighty":38.102301,"marketCap":2510698158},{"date":"2023-04-28","current":14.923106,"twenty":10.170468,"median":15.855634,"eighty":38.102301,"marketCap":2537912886},{"date":"2023-05-05","current":14.67685,"twenty":10.236823,"median":15.855634,"eighty":38.102301,"marketCap":2496033135},{"date":"2023-05-12","current":14.332092,"twenty":10.260952,"median":16.032017,"eighty":38.343175,"marketCap":2437401484},{"date":"2023-05-22","current":14.492158,"twenty":10.41424,"median":16.464097,"eighty":38.717161,"marketCap":2464623322},{"date":"2023-06-16","current":16.252887,"twenty":10.785762,"median":16.750679,"eighty":44.31339,"marketCap":2764063539},{"date":"2023-07-28","current":25.197394,"twenty":11.00463,"median":17.27564,"eighty":48.162223,"marketCap":2898431050},{"date":"2023-08-04","current":25.397618,"twenty":11.073225,"median":17.435046,"eighty":48.162223,"marketCap":2921462610},{"date":"2023-08-11","current":25.361232,"twenty":11.128106,"median":17.546519,"eighty":48.162223,"marketCap":2917277134},{"date":"2023-08-18","current":23.614691,"twenty":11.160198,"median":17.909423,"eighty":48.162223,"marketCap":2716374261},{"date":"2023-08-25","current":23.396373,"twenty":11.239305,"median":18.019188,"eighty":48.162223,"marketCap":2691261402},{"date":"2023-09-01","current":24.287837,"twenty":11.28108,"median":18.215803,"eighty":48.162223,"marketCap":2793805577},{"date":"2023-09-08","current":24.688086,"twenty":11.315392,"median":18.347724,"eighty":48.162223,"marketCap":2839845818},{"date":"2023-09-15","current":25.070142,"twenty":11.396477,"median":18.491041,"eighty":48.162223,"marketCap":2883793322},{"date":"2023-09-22","current":23.269021,"twenty":11.501531,"median":18.611422,"eighty":48.162223,"marketCap":2676612234},{"date":"2023-09-29","current":22.632261,"twenty":11.565241,"median":18.741258,"eighty":48.162223,"marketCap":2603366395},{"date":"2023-10-06","current":21.431514,"twenty":11.628551,"median":18.862611,"eighty":48.162223,"marketCap":2465245670},{"date":"2023-10-13","current":22.068274,"twenty":11.70682,"median":18.941436,"eighty":48.181924,"marketCap":2538491509},{"date":"2023-10-20","current":21.249583,"twenty":11.715669,"median":19.06654,"eighty":48.181924,"marketCap":2444318287},{"date":"2023-10-27","current":20.721982,"twenty":11.751549,"median":19.203657,"eighty":48.201625,"marketCap":2383628878},{"date":"2023-11-03","current":26.691875,"twenty":11.782919,"median":19.301672,"eighty":48.201625,"marketCap":2601817183},{"date":"2023-11-10","current":27.379035,"twenty":11.804156,"median":19.390769,"eighty":48.201625,"marketCap":2668798800},{"date":"2023-11-17","current":28.15209,"twenty":11.816178,"median":19.513046,"eighty":48.201625,"marketCap":2744153119},{"date":"2023-11-24","current":28.173564,"twenty":11.823271,"median":19.79217,"eighty":48.201625,"marketCap":2746246295},{"date":"2023-12-01","current":28.32388,"twenty":11.861543,"median":19.975607,"eighty":48.201625,"marketCap":2760898524},{"date":"2023-12-08","current":28.903671,"twenty":11.874946,"median":20.117452,"eighty":48.201625,"marketCap":2817414263},{"date":"2023-12-15","current":31.029573,"twenty":11.888522,"median":20.221885,"eighty":48.201625,"marketCap":3024638640},{"date":"2023-12-22","current":29.590831,"twenty":11.91034,"median":20.427474,"eighty":48.201625,"marketCap":2884395880},{"date":"2023-12-29","current":29.891464,"twenty":11.93663,"median":20.530884,"eighty":48.227893,"marketCap":2913700337},{"date":"2024-01-05","current":28.753355,"twenty":11.951044,"median":20.666113,"eighty":48.254161,"marketCap":2802762034},{"date":"2024-01-12","current":29.633779,"twenty":11.976942,"median":20.72975,"eighty":48.254161,"marketCap":2888582231},{"date":"2024-01-19","current":29.053988,"twenty":12.012067,"median":20.854609,"eighty":48.280428,"marketCap":2832066492},{"date":"2024-01-26","current":29.741148,"twenty":12.050866,"median":20.968389,"eighty":48.254161,"marketCap":2899048109},{"date":"2024-02-02","current":28.968093,"twenty":12.078465,"median":21.176825,"eighty":48.254161,"marketCap":2823693789},{"date":"2024-02-09","current":29.590831,"twenty":12.105337,"median":21.286574,"eighty":48.254161,"marketCap":2884395880},{"date":"2024-02-16","current":11.273805,"twenty":12.121334,"median":21.376935,"eighty":48.254161,"marketCap":2995483680},{"date":"2024-02-23","current":11.068969,"twenty":12.102013,"median":21.36612,"eighty":48.254161,"marketCap":2941058400},{"date":"2024-03-01","current":10.700192,"twenty":12.076695,"median":21.244812,"eighty":48.227893,"marketCap":2843073179},{"date":"2024-03-08","current":11.117799,"twenty":12.048043,"median":21.244812,"eighty":48.227893,"marketCap":2954032589},{"date":"2024-03-15","current":11.039005,"twenty":12.007676,"median":21.208433,"eighty":48.227893,"marketCap":2933096851},{"date":"2024-03-22","current":11.401457,"twenty":11.975106,"median":21.131335,"eighty":48.227893,"marketCap":3029401245},{"date":"2024-03-28","current":11.409336,"twenty":11.945735,"median":20.971378,"eighty":48.227893,"marketCap":3031494818},{"date":"2024-04-05","current":11.033059,"twenty":11.914716,"median":20.721982,"eighty":48.254161,"marketCap":2931516936},{"date":"2024-04-12","current":10.946309,"twenty":11.890995,"median":20.267582,"eighty":48.254161,"marketCap":2908467125},{"date":"2024-04-19","current":10.686058,"twenty":11.87564,"median":20.117452,"eighty":48.254161,"marketCap":2839317690},{"date":"2024-04-26","current":10.741263,"twenty":11.874946,"median":20.042474,"eighty":48.227893,"marketCap":2853985752},{"date":"2024-05-03","current":12.801669,"twenty":11.874946,"median":20.042474,"eighty":48.227893,"marketCap":2904276250},{"date":"2024-05-10","current":12.912467,"twenty":11.874946,"median":20.042474,"eighty":48.227893,"marketCap":2929412621},{"date":"2024-05-17","current":13.180322,"twenty":11.874946,"median":20.042474,"eighty":48.227893,"marketCap":2990180122},{"date":"2024-05-24","current":13.097195,"twenty":11.886038,"median":20.042474,"eighty":48.227893,"marketCap":2971321243},{"date":"2024-05-31","current":13.115667,"twenty":11.888522,"median":20.042474,"eighty":48.227893,"marketCap":2975512105},{"date":"2024-06-07","current":13.549777,"twenty":11.91541,"median":20.042474,"eighty":48.227893,"marketCap":3073997365},{"date":"2024-06-14","current":13.577487,"twenty":11.9744,"median":20.067408,"eighty":48.254161,"marketCap":3080283658},{"date":"2024-06-21","current":13.355813,"twenty":11.976264,"median":20.09243,"eighty":48.280428,"marketCap":3029993312},{"date":"2024-06-28","current":13.217268,"twenty":12.015039,"median":20.119651,"eighty":48.339531,"marketCap":2998561846},{"date":"2024-07-05","current":13.383523,"twenty":12.067158,"median":20.119651,"eighty":48.339531,"marketCap":3036279605},{"date":"2024-07-12","current":13.90076,"twenty":12.108178,"median":20.119651,"eighty":48.339531,"marketCap":3153623745},{"date":"2024-07-15","current":14.067015,"twenty":12.125501,"median":20.119651,"eighty":48.339531,"marketCap":3191341504},{"date":"2024-08-02","current":7.046799,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":3239829432},{"date":"2024-08-09","current":6.955638,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":3197917020},{"date":"2024-08-16","current":7.028567,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":3231446949},{"date":"2024-08-23","current":6.900941,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":3172769527},{"date":"2024-08-30","current":6.862197,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":3154956753},{"date":"2024-09-06","current":6.584154,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":3027123898},{"date":"2024-09-13","current":6.750524,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":3103614049},{"date":"2024-09-20","current":6.780151,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":3117235583},{"date":"2024-09-27","current":6.750524,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":3103614049},{"date":"2024-10-04","current":1.931488,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":888019212},{"date":"2024-10-11","current":1.961116,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":901640745},{"date":"2024-10-18","current":1.916675,"twenty":12.504257,"median":20.573716,"eighty":48.45117,"marketCap":881208445},{"date":"2024-10-25","current":1.956558,"twenty":12.199762,"median":20.573716,"eighty":48.45117,"marketCap":899545125},{"date":"2024-10-31","current":0.676862,"twenty":11.943647,"median":20.573716,"eighty":48.45117,"marketCap":860776145},{"date":"2024-11-08","current":1.136209,"twenty":11.975812,"median":20.642908,"eighty":48.464304,"marketCap":834056982},{"date":"2024-11-15","current":1.12479,"twenty":11.975812,"median":20.642908,"eighty":48.464304,"marketCap":825674500},{"date":"2024-11-22","current":1.154211,"twenty":11.975812,"median":20.642908,"eighty":48.464304,"marketCap":847271401},{"date":"2024-11-29","current":1.108499,"twenty":11.975812,"median":20.642908,"eighty":48.464304,"marketCap":813716098},{"date":"2024-12-06","current":1.0985,"twenty":11.975812,"median":20.642908,"eighty":48.464304,"marketCap":806375876},{"date":"2024-12-13","current":1.112785,"twenty":11.975812,"median":20.642908,"eighty":48.464304,"marketCap":816861908},{"date":"2024-12-20","current":1.072073,"twenty":11.975812,"median":20.642908,"eighty":48.464304,"marketCap":786976716},{"date":"2024-12-27","current":1.0935,"twenty":11.975812,"median":20.642908,"eighty":48.464304,"marketCap":802705764},{"date":"2025-01-03","current":1.071359,"twenty":11.975812,"median":20.642908,"eighty":48.464304,"marketCap":786452415},{"date":"2025-01-10","current":1.067788,"twenty":12.08223,"median":20.682445,"eighty":48.464304,"marketCap":783830906},{"date":"2025-01-17","current":1.0935,"twenty":12.08223,"median":20.682445,"eighty":48.464304,"marketCap":802705764},{"date":"2025-01-24","current":1.089215,"twenty":12.08223,"median":20.682445,"eighty":48.464304,"marketCap":799559955},{"date":"2025-01-31","current":1.087786,"twenty":12.08223,"median":20.682445,"eighty":48.464304,"marketCap":798511352},{"date":"2025-02-07","current":1.082072,"twenty":12.08223,"median":20.682445,"eighty":48.464304,"marketCap":794316939},{"date":"2025-02-14","current":1.078501,"twenty":11.967771,"median":20.573716,"eighty":48.464304,"marketCap":791695431},{"date":"2025-02-21","current":1.05136,"twenty":11.815098,"median":20.171841,"eighty":48.464304,"marketCap":771771969},{"date":"2025-02-28","current":1.360481,"twenty":11.549812,"median":20.042474,"eighty":48.464304,"marketCap":723536221},{"date":"2025-03-07","current":1.287534,"twenty":11.27329,"median":19.867491,"eighty":48.464304,"marketCap":684741350},{"date":"2025-03-14","current":1.248099,"twenty":11.172328,"median":19.867235,"eighty":48.464304,"marketCap":663769180},{"date":"2025-03-21","current":1.261901,"twenty":11.161297,"median":19.867235,"eighty":48.464304,"marketCap":671109440},{"date":"2025-03-28","current":1.258944,"twenty":11.155562,"median":19.867235,"eighty":48.464304,"marketCap":669536527},{"date":"2025-04-04","current":1.190919,"twenty":11.155562,"median":19.867235,"eighty":48.464304,"marketCap":633359534},{"date":"2025-04-11","current":1.122895,"twenty":11.140266,"median":19.79217,"eighty":48.464304,"marketCap":597182540},{"date":"2025-04-17","current":1.148527,"twenty":11.117799,"median":19.79217,"eighty":48.464304,"marketCap":610814451},{"date":"2025-04-25","current":1.17547,"twenty":11.123737,"median":19.867235,"eighty":48.464304,"marketCap":625143243},{"date":"2025-05-02","current":1.17547,"twenty":11.111923,"median":19.867235,"eighty":48.464304,"marketCap":625143243},{"date":"2025-05-09","current":1.131612,"twenty":11.111923,"median":19.867235,"eighty":48.464304,"marketCap":631961020},{"date":"2025-05-16","current":1.159785,"twenty":11.111923,"median":19.867235,"eighty":48.464304,"marketCap":647694490},{"date":"2025-05-23","current":1.103439,"twenty":11.111122,"median":19.867235,"eighty":48.464304,"marketCap":616227551},{"date":"2025-05-30","current":1.125977,"twenty":11.105833,"median":19.867235,"eighty":48.464304,"marketCap":628814327},{"date":"2025-06-06","current":1.094987,"twenty":11.039005,"median":19.867235,"eighty":48.464304,"marketCap":611507510},{"date":"2025-06-13","current":1.115647,"twenty":10.945567,"median":19.867235,"eighty":48.464304,"marketCap":623045388}],"updateTime":1750085626793}}}